← Back to headlines
Biotech Stocks Gain After FDA Reverses Stance on UniQure
Regenxbio and Replimune were among the top gainers in the biotech sector following a U-turn by the FDA regarding UniQure, indicating a positive market response to the regulatory development.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippines Grapples with Plastic Waste Leakage Despite Existing Laws
just now
Visayas Sugar Farms Face Insect Infestation, Prompting Emergency Meeting
just now
Philippines: Loboc River P3.5-B Protection Project Under Scrutiny
just now